Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Volume 3 Supplement 1

ESICM LIVES 2015

Relationship between transcutaneous C02 measurement and PAC02 during non invasive ventilation delivered because of hypercapnic acute respiratory failure

Introduction

Non-invasive ventilation (NIV) is the first line supportive treatment in case of acute hypercapnic respiratory failure (AHRF). NIV efficacy is continuously monitored using clinical parameters (respiratory frequency, use of accessory respiratory muscles). The assessment of NIV efficacy however usually requires repeated blood gas analysis after 30 or 60 minutes of treatment. A reliable non-invasive technique to continuously monitor PaC02 during NIV could simplify this evaluation and allow an earlier adaptation of ventilator settings.

Objectives

The aim of this study was to assess whether measuring transcutaneous C02 (TpC02) during NIV delivered because of AHRF could be of interest for evaluating PaC02.

Methods

ICU patients requiring NIV for AHRF (PaC02 >42 mmHg) were included in this prospective observational study. TpC02 was measured during a 60-minute NIV treatment using a dedicated auricular sensor and the Sentec monitor (Sentec, Switzerland), connected to the patient 15 minutes before the start of NIV. Blood gas analysis and TcC02 recording were performed before initiating NIV and after 30, 45 and 60 minutes of NIV.The correlation between PaC02 and TpC02 was assessed by linear regression (Spearman) and intraclass correlation coefficient (ICC). The agreement between both techniques was assessed using the Bland and Altmann method for repeated measurements.

Results

20 patients (11 women; 9 men, 17 with obstructive pulmonary disease, 1 with restrictive disease and 2 without chronic lung disease) were included in the study. Age 65 [61-72] years II score 32 [28-46]. At inclusion, PaC02 was 57 [51-68] mmHg, Sa02 94 [92-95] % and respiratory rate 25 [21-29] /min. PaC02 values ranged from 43 to 80 mmHg whereas TpC02 values ranged from 42 to 84 mmHg. The correlation coefficient RSAPS 2 between PaC02 and TpC02 values was 0.84. The ICC was 0.906. Bland and Altmann graph is illustrated in figure 1. The bias was -1.4 mmHg and the limits of agreement were -10.1 and 7.3 mmHg.

figure1

Figure 1

Conclusions

In a small group of patients undergoing NIV for acute hypercapnic respiratory failure the agreement between TpC02 and PaC02 was very good. This suggests that C02 transcutaneous measurement could be of interest to evaluate the course of PaC02 during NIV.

Author information

Correspondence to D Thévoz.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Intraclass Correlation Coefficient
  • Acute Respiratory Failure
  • Respiratory Muscle
  • Prospective Observational Study
  • Chronic Lung Disease